Generative AI
Healthcare
Microsoft Azure, OpenAI’s NLP
A California-based company that uses genomics and artificial intelligence to discover and develop new drugs for various types of cancer. The company aims to accelerate the drug discovery process by analyzing large amounts of genomic data and generate novel molecules with therapeutic potential.
Reviewing clinical trial protocols was a cumbersome, labor-intensive process that was prone to error. Documentation was extensive, and ensuring accuracy and compliance was time consuming. The client was not just concerned about improving efficiency, but also about delivering safe treatments to their patients.
Key challenges
WinWire’s solution redefines how our client reviews clinical trial documents and protocols. Utilizing Microsoft Azure and OpenAI’s sophisticated NLP technology, the solution rapidly examines large documents, identifies mistakes, and ensures compliance.
Highlights of the solution include: